Efficacy of the treatment using a microemulsion loaded with epoxy-α-lapachone in combination with meglumine antimoniate against murine infection by Leishmania (Leishmania) amazonensis. [PDF]
Int J Parasitol Drugs Drug ResistPeixoto JF +12 more
europepmc +1 more source
Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis. [PDF]
Front Pharmacol, 2019 Vargas DA +6 more
europepmc +1 more source
Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis. [PDF]
Int J Parasitol Drugs Drug Resist, 2019 Goyonlo VM, Vahabi-Amlashi S, Taghavi F.
europepmc +1 more source
Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: A cost-effectiveness analysis. [PDF]
PLoS Negl Trop Dis, 2019 Brito NC +3 more
europepmc +1 more source
Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis. [PDF]
Pharmaceutics, 2019 Berenguer D +8 more
europepmc +1 more source
The effect of Nd:YAG laser therapy on cutaneous leishmaniasis compared to intralesional meglumine antimoniate. [PDF]
Postepy Dermatol Alergol, 2019 Omidian M +3 more
europepmc +1 more source
Resistance of Leishmania (Viannia) Panamensis to Meglumine Antimoniate or Miltefosine Modulates Neutrophil Effector Functions. [PDF]
Front Immunol, 2018 Regli IB +5 more
europepmc +1 more source
Hoigne Syndrome Caused by Intralesional Meglumine Antimoniate. [PDF]
Open Access Maced J Med Sci, 2017 Guarneri C +3 more
europepmc +1 more source